BR9712058B1 - formulações para uso de ivermectina, processo para sua preparação e uso. - Google Patents
formulações para uso de ivermectina, processo para sua preparação e uso.Info
- Publication number
- BR9712058B1 BR9712058B1 BRPI9712058-8A BR9712058A BR9712058B1 BR 9712058 B1 BR9712058 B1 BR 9712058B1 BR 9712058 A BR9712058 A BR 9712058A BR 9712058 B1 BR9712058 B1 BR 9712058B1
- Authority
- BR
- Brazil
- Prior art keywords
- ivermectin
- formulations
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI9715298A BRPI9715298B8 (pt) | 1996-09-18 | 1997-09-08 | formulações para injeção de avermectinas ou milbemicinas para uso veterinário, processo para sua preparação e uso |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19638045A DE19638045A1 (de) | 1996-09-18 | 1996-09-18 | Injektionsformulierungen von Avermectinen und Milbemycinen |
PCT/EP1997/004867 WO1998011902A1 (de) | 1996-09-18 | 1997-09-08 | Injektionsformulierungen von avermectinen und milbemycinen |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9712058A BR9712058A (pt) | 1999-08-24 |
BR9712058B1 true BR9712058B1 (pt) | 2009-05-05 |
Family
ID=7806009
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9712058-8A BR9712058B1 (pt) | 1996-09-18 | 1997-09-08 | formulações para uso de ivermectina, processo para sua preparação e uso. |
BRPI9715298A BRPI9715298B8 (pt) | 1996-09-18 | 1997-09-08 | formulações para injeção de avermectinas ou milbemicinas para uso veterinário, processo para sua preparação e uso |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9715298A BRPI9715298B8 (pt) | 1996-09-18 | 1997-09-08 | formulações para injeção de avermectinas ou milbemicinas para uso veterinário, processo para sua preparação e uso |
Country Status (18)
Country | Link |
---|---|
US (1) | US6617314B2 (pt) |
EP (1) | EP0939638B1 (pt) |
JP (1) | JP4822196B2 (pt) |
KR (1) | KR20000035978A (pt) |
CN (1) | CN1130203C (pt) |
AR (1) | AR008844A1 (pt) |
AT (1) | ATE228845T1 (pt) |
AU (1) | AU750874B2 (pt) |
BR (2) | BR9712058B1 (pt) |
CA (1) | CA2265952C (pt) |
DE (2) | DE19638045A1 (pt) |
DK (1) | DK0939638T3 (pt) |
ES (1) | ES2184135T3 (pt) |
HK (1) | HK1022845A1 (pt) |
NZ (1) | NZ334673A (pt) |
PL (1) | PL332137A1 (pt) |
WO (1) | WO1998011902A1 (pt) |
ZA (1) | ZA978352B (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
KR20000025762A (ko) * | 1998-10-14 | 2000-05-06 | 유충식 | 이버멕틴류의 가용화 조성물 |
GB9827727D0 (en) * | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
US6872708B2 (en) * | 2001-09-10 | 2005-03-29 | Mitsukazu Matsumoto | Local injection prescription |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
US7582612B2 (en) | 2004-03-12 | 2009-09-01 | Hartz Mountain Corporation | Multi-action anthelmintic formulations |
NZ590141A (en) * | 2008-06-24 | 2012-05-25 | Merial Ltd | Anthelminthic formulations including castor oil and another vegetable oil |
CA2750626C (en) * | 2009-02-16 | 2013-10-01 | Pfizer Inc. | High dosage doramectin formulation |
CN101773467B (zh) * | 2010-01-20 | 2015-09-09 | 北京大北农动物保健科技有限责任公司 | 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法 |
US20110223208A1 (en) * | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
WO2011112669A1 (en) * | 2010-03-09 | 2011-09-15 | Centocor Ortho Biotech Inc. | Non-aqueous high concentration reduced viscosity suspension formulations |
CA2867079A1 (en) | 2012-03-13 | 2013-09-19 | Bayer New Zealand Limited | Long acting compositions |
CN103417478B (zh) * | 2012-05-18 | 2014-09-10 | 中国农业科学院兰州畜牧与兽药研究所 | 一种以水为基质的伊维菌素o/w型注射液及其制备方法 |
WO2017119928A1 (en) * | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long acting injectable formulations |
US20210137960A1 (en) | 2018-02-01 | 2021-05-13 | Yale University | Compositions and methods for inhibition of nuclear-penetrating antibodies |
CN114107097B (zh) * | 2021-11-10 | 2024-03-05 | 河北兴柏农业科技股份有限公司 | 一种阿佛曼链霉菌活性孢子的固体发酵工艺 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
OA06863A (fr) * | 1980-08-04 | 1983-02-28 | Merck & Co Inc | Solubilisation de l'invermectine dans l'eau. |
NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
EP0393890B1 (en) * | 1989-04-11 | 1992-08-12 | Pfizer Limited | Injectable compositions containing 25-cyclohexyl-avermectin b1 |
US6001822A (en) * | 1989-04-11 | 1999-12-14 | Pfizer Inc. | Antiparasitic formulations |
NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
US5055486A (en) | 1989-12-22 | 1991-10-08 | American Cyanamid Company | 13-alkyl-23-imino derivative of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents |
US5030650A (en) | 1989-09-11 | 1991-07-09 | American Cyanamid Company | 13-halo-23-imino derivatives of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents |
DE69208765T2 (de) * | 1991-07-23 | 1996-09-26 | American Cyanamid Co | Stabile Zusammensetzungen für parenterale Verabrechung und ihre Verwendung |
ES2131515T3 (es) * | 1991-09-30 | 1999-08-01 | Merck & Co Inc | Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado. |
GB2275193A (en) * | 1993-02-17 | 1994-08-24 | Merck & Co Inc | Formulations for the topical delivery of avermectins |
DE4443888A1 (de) * | 1994-12-09 | 1996-06-13 | Bayer Ag | Dermal applizierbare Formulierungen von Parasitiziden |
DE69636706T2 (de) * | 1995-09-25 | 2007-10-11 | Ashmont Holdings Ltd., Takapuna | Makrocyclische lacton anthelmintika |
DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
RU2140737C1 (ru) * | 1998-09-22 | 1999-11-10 | Мосин Владимир Александрович | Средство для профилактики и лечения паразитарных заболеваний животных |
CN1219393A (zh) * | 1998-11-13 | 1999-06-16 | 王玉万 | 一种含阿维菌素或伊维菌素的兽用抗寄生虫油剂口服液及其制备方法 |
-
1996
- 1996-09-18 DE DE19638045A patent/DE19638045A1/de not_active Withdrawn
-
1997
- 1997-09-08 AU AU46215/97A patent/AU750874B2/en not_active Ceased
- 1997-09-08 DK DK97944849T patent/DK0939638T3/da active
- 1997-09-08 AT AT97944849T patent/ATE228845T1/de active
- 1997-09-08 ES ES97944849T patent/ES2184135T3/es not_active Expired - Lifetime
- 1997-09-08 JP JP51423798A patent/JP4822196B2/ja not_active Expired - Fee Related
- 1997-09-08 CN CN97198028A patent/CN1130203C/zh not_active Expired - Fee Related
- 1997-09-08 US US09/254,615 patent/US6617314B2/en not_active Expired - Lifetime
- 1997-09-08 CA CA002265952A patent/CA2265952C/en not_active Expired - Lifetime
- 1997-09-08 WO PCT/EP1997/004867 patent/WO1998011902A1/de active IP Right Grant
- 1997-09-08 BR BRPI9712058-8A patent/BR9712058B1/pt not_active IP Right Cessation
- 1997-09-08 KR KR1019997001893A patent/KR20000035978A/ko not_active Application Discontinuation
- 1997-09-08 DE DE59708905T patent/DE59708905D1/de not_active Expired - Lifetime
- 1997-09-08 BR BRPI9715298A patent/BRPI9715298B8/pt active IP Right Grant
- 1997-09-08 NZ NZ334673A patent/NZ334673A/xx not_active IP Right Cessation
- 1997-09-08 EP EP97944849A patent/EP0939638B1/de not_active Expired - Lifetime
- 1997-09-08 PL PL97332137A patent/PL332137A1/xx unknown
- 1997-09-17 ZA ZA9708352A patent/ZA978352B/xx unknown
- 1997-09-18 AR ARP970104297A patent/AR008844A1/es active IP Right Grant
-
2000
- 2000-03-31 HK HK00101987A patent/HK1022845A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE19638045A1 (de) | 1998-03-19 |
ZA978352B (en) | 1998-03-24 |
ES2184135T3 (es) | 2003-04-01 |
HK1022845A1 (en) | 2000-08-25 |
JP2001503029A (ja) | 2001-03-06 |
CN1230890A (zh) | 1999-10-06 |
ATE228845T1 (de) | 2002-12-15 |
US6617314B2 (en) | 2003-09-09 |
EP0939638A1 (de) | 1999-09-08 |
AU750874B2 (en) | 2002-08-01 |
AU4621597A (en) | 1998-04-14 |
KR20000035978A (ko) | 2000-06-26 |
JP4822196B2 (ja) | 2011-11-24 |
CA2265952A1 (en) | 1998-03-26 |
BRPI9715298B8 (pt) | 2016-04-26 |
EP0939638B1 (de) | 2002-12-04 |
WO1998011902A1 (de) | 1998-03-26 |
CA2265952C (en) | 2009-11-17 |
US20020160967A1 (en) | 2002-10-31 |
AR008844A1 (es) | 2000-02-23 |
DK0939638T3 (da) | 2003-03-24 |
BR9712058A (pt) | 1999-08-24 |
CN1130203C (zh) | 2003-12-10 |
BR9715298B1 (pt) | 2014-10-14 |
DE59708905D1 (de) | 2003-01-16 |
PL332137A1 (en) | 1999-08-30 |
NZ334673A (en) | 2000-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9712058B1 (pt) | formulações para uso de ivermectina, processo para sua preparação e uso. | |
BR9810116B1 (pt) | composição de solução e processo para sua preparação. | |
BR9708400A (pt) | Composição sua preparação e uso | |
BR9916192B1 (pt) | formulações agroquìmicas, processo para a sua preparação e uso das mesmas. | |
BR9808422B1 (pt) | composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto. | |
BR9909995B1 (pt) | composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto. | |
BR9804378B1 (pt) | compostos, processo para sua produção e uso. | |
PT934915E (pt) | Betao de muito alto desempenho, autonivelante, processo para a preparacao do mesmo e sua utilizacao | |
BR9815047B1 (pt) | composição de aditivo para borracha, processo para sua preparação e sua aplicação. | |
BR9603429A (pt) | Derivado de 11-(fenila substituída) estra-4,9-dieno processo de preparação do mesmo composição farmacêutica e uso deste derivado | |
BR9601093A (pt) | Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização | |
BR9801652B1 (pt) | resorcinil-triazina, processo para preparaÇço e uso da mesma e composiÇço cosmÉtica. | |
BR9000116A (pt) | Alfa-diazo-beta-cetoester polifuncional,processo para sua preparacao e sua utilizacao | |
FI103704B1 (fi) | Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö | |
BR9600147A (pt) | Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso | |
BR9711311B1 (pt) | derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos. | |
BR9710739B1 (pt) | polissacarÍdeos sintÉticos, processo para sua preparaÇço, composiÇÕes farmacÊuticas que os contÊm e utilizaÇço dos mesmos. | |
BR9713977B1 (pt) | composto análogo de comptotecina, e, utilização e processo para preparação do mesmo. | |
BR9602025A (pt) | Composto composição farmacêutica uso e processo para a preparação de um composto | |
BR9600778A (pt) | Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento | |
BR9500671A (pt) | Veículos para vernizes,processo para sua preparação e uso | |
EE03387B1 (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
BR9600779A (pt) | Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento | |
BR0012329B1 (pt) | derivados de benzofurano, processo para sua preparaÇço e uso dos mesmos. | |
BR9302359A (pt) | Composto,processo para sua preparacao,medicamento e uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/06/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER ANIMAL HEALTH GMBH (DE) Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE) |
|
B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 31/71; A61K 47/10; A61K 47/14; A61K 47/44. Ipc: A61K 31/7048 (2006.01), A61K 9/00 (2006.01), A61K Ipc: A61K 31/7048 (2006.01), A61K 9/00 (2006.01), A61K |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 30.06.2019 |